David Sarne to Thyroid Neoplasms
This is a "connection" page, showing publications David Sarne has written about Thyroid Neoplasms.
Connection Strength
1.046
-
A piece of the puzzle: what does BRAF status mean in the management of patients with papillary thyroid carcinoma? J Clin Endocrinol Metab. 2012 Sep; 97(9):3094-6.
Score: 0.273
-
Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab. 2005 Dec; 1(2):82-91.
Score: 0.171
-
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma. Endocr Pathol. 2025 Apr 16; 36(1):13.
Score: 0.164
-
The Significance of RAS-Like Mutations and MicroRNA Profiling in Predicting Malignancy in Thyroid Biopsy Specimens. Endocr Pathol. 2022 Dec; 33(4):446-456.
Score: 0.138
-
A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines. Thyroid. 2020 01; 30(1):25-33.
Score: 0.114
-
Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Endocr Pathol. 2018 Mar; 29(1):9-14.
Score: 0.100
-
External radiation and thyroid neoplasia. Endocrinol Metab Clin North Am. 1996 Mar; 25(1):181-95.
Score: 0.087